Tracky Expands India’s Connected Continuous Glucose Monitoring Ecosystem Through Strategic Digital Health Collaborations with TatvaCare
TRACKY, India’s first Bluetooth-enabled CGM, integrates with TatvaCare
Partnership expands real-time glucose monitoring and data-driven diabetes care in India
Collaboration supports digital management of diabetes, chronic kidney disease, and post-transplant metabolic care
Partnership combines connected biosensing technology and digital health infrastructure to support continuous metabolic monitoring and more proactive disease management.
DrStore Healthcare Services India, a connected healthcare and medical device ecosystem company, today announced a strategic partnership with TatvaCare’s Health & Wellness app GoodFlip, an integrated platform focused on cardio-metabolic health to expand access to Continuous Glucose Monitoring (CGM) technologies and strengthen digital diabetes care infrastructure in India. The partnership integrates DrStore’s connected medical device brand, TRACKY, which introduced India’s first Bluetooth-enabled continuous glucose monitoring (CGM) system, with TatvaCare’s GoodFlip app, enabling real-time glucose monitoring and more data-driven management of diabetes, chronic kidney disease, post-transplant metabolic management, and other metabolic conditions.
Through this partnership, the companies will deploy connected CGM solutions across digital care programs and specialised clinical pathways. By combining TRACKY’s connected biosensing technology with TatvaCare’s digital health infrastructure, clinicians will be able to monitor glucose trends remotely and support more proactive, personalised disease management for high-risk patient groups patients across India.
The partnership will also focus on specialised care pathways, including patients with chronic kidney disease and those requiring post-transplant metabolic management. These patient populations frequently experience significant glycaemic variability due to immunosuppressive therapies, steroid use, and complex metabolic changes, making continuous glucose monitoring an important tool for improving glycaemic control and clinical outcomes.
TRACKY launched India’s first Bluetooth-connected continuous glucose monitoring system in 2025, marking a breakthrough in the country’s CGM technology landscape and ushering in a new era of connected diabetes care. By enabling seamless real-time transmission of glucose data to digital health platforms, the technology moves CGM beyond standalone monitoring to become part of a broader, data-driven ecosystem for metabolic health management.
“Continuous monitoring technologies are redefining how metabolic diseases are managed globally,” said Neeraj Katare, Founder of DrStore Healthcare Services India Private Limited. “With TRACKY, our vision has been to build a connected biosensing platform that integrates advanced medical devices with digital health ecosystems. Launching India’s first Bluetooth-connected CGM was an important step in that journey. As adoption of continuous monitoring accelerates, we see tremendous potential in building an integrated metabolic monitoring ecosystem that enables clinicians and patients to move from episodic testing to real-time, data-driven care.”
“Digital health platforms are playing an increasingly critical role in enabling more personalised and continuous care pathways,” said Manoj Balaji, Chief Executive Officer at TatvaCare. “By integrating TRACKY’s connected CGM technology within TatvaCare’s ecosystem, we aim to extend access to clinicians with deeper metabolic insights and enable patients to benefit from more proactive and technology-enabled disease management.”
For TRACKY, the collaboration represents part of a broader effort to build an integrated continuous metabolic monitoring platform that extends beyond glucose monitoring. The company is actively working on next-generation technologies aimed at enabling continuous monitoring of multiple metabolic and cardiovascular biomarkers, creating a unified platform for real-time metabolic health insights.
In parallel, TRACKY is also exploring digital health applications that support metabolic therapy management, including emerging care models around GLP-1-based weight-loss therapies. By combining connected biosensors, digital health platforms, and data-driven insights, the company aims to enable a more holistic and personalised approach to metabolic health management.
As the burden of metabolic diseases such as diabetes, obesity, and cardiovascular disorders continues to rise globally, the convergence of connected medical devices, biosensing innovation, and digital health platforms is expected to play a critical role in enabling more preventive, personalised, and continuous models of care. As adoption of continuous glucose monitoring accelerates across healthcare providers, digital health platforms, and specialised clinical programs in India, connected CGM technologies are increasingly being integrated into broader chronic disease management ecosystems.
Got a story that Healthcare Executive should dig into? Shoot it over to arunima.rajan@hosmac.com—no PR fluff, just solid leads.